The aggressive breast cancer prognosis depends on demographic characteristics (age, menopausal status), tumoral (lymph node status, tumor size, pathologic type) and biological markers (presence or absence of HER2, the cathepsin D level). The gene discussed is ERBB2; the disease is breast cancer.